Intas Pharmaceuticals Ltd and Henlius Biotech enter into Exclusive License Agreement to commercialise serplulimab – A Novel Anti-PD1 mAb in Europe & India
Pti: Intas Pharmaceuticals Ltd and Henlius Biotech enter into Exclusive License Agreement to commercialise serplulimab – A Novel Anti-PD1 mAb in Europe & India